Pain News and Research

Latest Pain News and Research

Teva contributes $2.5M to The Franklin Institute for development of neuroscience exhibit

The Franklin Institute has received a $2.5 million contribution from leading global pharmaceutical company Teva Pharmaceuticals to develop a signature innovative exhibit at the museum exploring neuroscience and the human brain, entitled Your Brain. This contribution brings The Franklin Institute's Inspire Science fundraising campaign total to $65 million.

20 Jul 2012

Nuvo Research receives first three Pliaglis marketing licenses from E.U. countries

Nuvo Research Inc., a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain today announced that Galderma S.A. (Galderma), a global company dedicated to dermatology has received its first three Pliaglis marketing licenses from E.U. countries.

20 Jul 2012

Delaware district court upholds Pfizer's patents for LYRICA to treat pain and seizures

Pfizer Inc. announced today that the United States District Court for the District of Delaware upheld its composition of matter patent and pain and seizure use patents covering LYRICA (pregabalin) capsules CV. With this decision, Pfizer will exclusively provide pregabalin as LYRICA to patients through December 30, 2018 in the U.S., pending generic company appeal and further litigation.

20 Jul 2012

Cubist second quarter total net revenues increase 30% to $230.6M

Cubist Pharmaceuticals, Inc. today announced results for the second quarter ended June 30, 2012.

20 Jul 2012

Apothecary, Verde introduce Medsaway medication disposal system

Apothecary Products, Inc., in conjunction with Verde Environmental Technologies, introduces Medsaway medication disposal system. This unique item allows you to get rid of old and unwanted drugs including narcotics, liquid medication, transdermal patches and controlled substances.

20 Jul 2012

BioAlliance Pharma, Vestiq enter license agreement for Oravig to treat oropharyngeal candidiasis

BioAlliance Pharma SA, an innovative Company dedicated to the development of orphan oncology products and to supportive care products, announces it has signed a binding term sheet with Vestiq for the commercialization rights in the United States of Oravig (known as Loramyc in Europe) for the treatment of oropharyngeal candidiasis in adults.

20 Jul 2012

Longer looks: Physicians and assisted suicide; Avoid getting sick in July

Peggy Sutherland was ready to die. The morphine oozing from a pump in her spine was no match for the pain of lung cancer, which had evaded treatment and invaded her ribs. … Sutherland, 68, decided to use Oregon's "Death With Dignity Act," which allows terminally-ill residents to end their lives after a 15-day requisite waiting period by self-administering a lethal prescription drug. ... But not all doctors are on board with the law.

20 Jul 2012

Lifescript introduces new online health center for women with fibromyalgia

Lifescript.com, a women's health and wellness website headquartered in Mission Viejo, Calif., has launched a new online Fibromyalgia Health Center, designed to help women treat and reduce the frustrations and pain of fibromyalgia.

20 Jul 2012

Roundup: Minn. health care spending slows; Fla. counties may reconsider Medicaid lawsuit against state; Accessing dental care in Georgia

The state Health Department reports the rate of health care spending in Minnesota has slowed to its lowest point since 1997. Health care costs are still rising, but at a much slower pace -- 2.2 percent between 2009 and 2010. State Health Economist Stefan Gildemeister said the recession was a major factor in why Minnesotans spent less on health care. He said many lost their insurance when they lost their jobs and others who kept their jobs were more cautious.

20 Jul 2012

Hyperoxygenation postsurgery benefits in doubt

Supplementation with 80% fraction of inspired oxygen during surgery does not reduce patients’ risk for surgical site infections, research shows.

19 Jul 2012

Extraosseous talotarsal stabilization improves hyperpronation

Radiographic outcomes show that extraosseous talotarsal stabilization may be helpful in reducing or eliminating hyperpronation, resulting in less pain and improved foot function.

19 Jul 2012

Non-motor Parkinson’s disease symptoms show variable course

The non-motor symptoms of patients with Parkinson’s disease show a variable evolution that does not follow motor deterioration and is symptom specific, results of a 2-year follow-up study show.

19 Jul 2012

Ellman International acquires Sandstone Medical Technologies

Ellman International, Inc., a global leader in advanced radiofrequency (RF) technology for precision surgical and aesthetic procedures today announced that it has acquired the assets of Sandstone Medical Technologies, LLC., a recognized leader in the aesthetic laser and IPL technology field.

19 Jul 2012

Primcogent Solutions introduces low level laser therapy for onychomycosis

Primcogent Solutions - supplier of the revolutionary ZERONA non-invasive body contouring technology in North America and Western Europe - has announced the launch of Lunula Laser, a clinically proven, low level laser therapy for onychomycosis, for distribution exclusively in Europe.

19 Jul 2012

First Edition: July 19, 2012

Today's headlines include a variety of stories exploring public opinions about the health law, the upcoming election and the Supreme Court.

19 Jul 2012

EMA accepts Pfizer’s bazedoxifene/conjugated estrogens MAA for review

Pfizer Inc. today announced that the European Medicines Agency (EMA) accepted for review the Marketing Authorization Application (MAA) for bazedoxifene/conjugated estrogens (BZA/CE), a potential new medicine for postmenopausal women with a uterus for the treatment of estrogen deficiency symptoms and treatment of osteoporosis in women at risk of fracture.

19 Jul 2012

Huddersfield scientist receives Pain Relief Foundation grant for research into BH4 pathway

SOME victims of serious illness experience much less pain than other sufferers, thanks to a natural biochemical variation in the cells of their bodies. Now a scientist at the University of Huddersfield has been awarded research funding that will aid his project to learn more about this variation and therefore develop treatments that could lead to the relief of pain for all patients, with much less dependence on drugs that can have distressing side effects.

19 Jul 2012

Positive preliminary results from Feraheme phase III study on iron deficiency anemia

AMAG Pharmaceuticals, Inc. today reported preliminary results from the second phase III study from its global registrational program for Feraheme (ferumoxytol) in patients with iron deficiency anemia (IDA) regardless of the underlying cause.

19 Jul 2012

Otsuka, Acucela commence rebamipide ophthalmic suspension Phase 3 trial in dry eye syndrome

Acucela Inc., a clinical stage biotechnology company focused on developing new treatments for blinding eye diseases, and Otsuka Pharmaceutical Co., Ltd., today announced the initiation of a Phase 3 clinical trial to evaluate rebamipide ophthalmic suspension in patients with dry eye syndrome.

19 Jul 2012

Roundup: Ore. issues new long-term care insurance claims rules; Fla. pushing ahead with prison care privatization

The Oregon Insurance Division receives about 100 complaints about long-term-care policies each year, mostly about delays or denials. But now the state's role is increasing, thanks to a law that went into effect this month. The Oregon law requires insurers to process long-term care claims within 30 days when they're not in dispute. It also allows outside review when an insurer decides a person isn't sufficiently disabled for long-term care.

19 Jul 2012

Pain News and Research

Latest Pain News and Research

Teva contributes $2.5M to The Franklin Institute for development of neuroscience exhibit

Nuvo Research receives first three Pliaglis marketing licenses from E.U. countries

Delaware district court upholds Pfizer's patents for LYRICA to treat pain and seizures

Cubist second quarter total net revenues increase 30% to $230.6M

Apothecary, Verde introduce Medsaway medication disposal system

BioAlliance Pharma, Vestiq enter license agreement for Oravig to treat oropharyngeal candidiasis

Longer looks: Physicians and assisted suicide; Avoid getting sick in July

Lifescript introduces new online health center for women with fibromyalgia

Roundup: Minn. health care spending slows; Fla. counties may reconsider Medicaid lawsuit against state; Accessing dental care in Georgia

Hyperoxygenation postsurgery benefits in doubt

Extraosseous talotarsal stabilization improves hyperpronation

Non-motor Parkinson’s disease symptoms show variable course

Ellman International acquires Sandstone Medical Technologies

Primcogent Solutions introduces low level laser therapy for onychomycosis

First Edition: July 19, 2012

EMA accepts Pfizer’s bazedoxifene/conjugated estrogens MAA for review

Huddersfield scientist receives Pain Relief Foundation grant for research into BH4 pathway

Positive preliminary results from Feraheme phase III study on iron deficiency anemia

Otsuka, Acucela commence rebamipide ophthalmic suspension Phase 3 trial in dry eye syndrome

Roundup: Ore. issues new long-term care insurance claims rules; Fla. pushing ahead with prison care privatization

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Pain News and Research

Latest Pain News and Research

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Newsletters you may be interested in